Amin N, Soulby AJ, Borsetto D, et al. - In this investigation, the authors present the outcomes of an economic analysis comparing the two bone conduction implants (BCI) systems ie, Bonebridge 601 and percutaneous bone‐anchored hearing devices (pBAHDs). The sample consisted of adult patients (≥ 16 years) with conductive hearing loss, mixed hearing loss or single‐sided deafness, who received a Bonebridge or pBAHD implant between 1/7/2013 and 1/12/2018 with a minimum 12‐month follow‐up. Bonebridge's long-term costs to healthcare providers are similar to pBAHDs, whilst offering lower complication rates, comparable audiological benefit and patient satisfaction. In appropriate cases, Bonebridge should be taken into account as a first-line BCI alternative.